BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8372052)

  • 1. Furosemide treatment causes age-dependent glucose intolerance and islet damage in obese-hyperglycaemic mice.
    Sandström PE; Sehlin J; Amark K
    Pharmacol Toxicol; 1993; 72(4-5):304-9. PubMed ID: 8372052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furosemide-induced glucose intolerance in mice is associated with reduced insulin secretion.
    Sandström PE; Sehlin J
    Eur J Pharmacol; 1988 Mar; 147(3):403-9. PubMed ID: 3288480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation.
    Edvell A; Lindström P
    Am J Physiol; 1998 Jun; 274(6):E1034-9. PubMed ID: 9611153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effects on glycosylated blood proteins in lean and obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ; Cameron AM; Gould BJ
    Diabetes Res; 1986 Jun; 3(5):241-3. PubMed ID: 3742944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice.
    Panagiotidis G; Lindström P; Stenström A; Lundquist I
    Metabolism; 1993 Nov; 42(11):1398-404. PubMed ID: 8231833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furosemide causes acute and long-term hyperglycaemia and reduces glucose tolerance in mice.
    Sandström PE; Sehlin J
    Acta Physiol Scand; 1988 Jan; 132(1):75-81. PubMed ID: 3066121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous islet uncoupling protein-2 expression and loss of glucose homeostasis in ob/ob mice.
    Saleh MC; Wheeler MB; Chan CB
    J Endocrinol; 2006 Sep; 190(3):659-67. PubMed ID: 17003267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of successful intrasplenic transplantation of islets from lean mice to cure obese-hyperglycaemic mice, despite islet growth.
    Andersson A; Eriksson U; Petersson B; Reibring L; Swenne I
    Diabetologia; 1981 Mar; 20(3):237-41. PubMed ID: 6785138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet organ, blood glucose and glucose tolerance of lean and obese Mongolian gerbils. A quantitative study.
    Lucocq JM; Findlay JA
    Cell Tissue Res; 1981; 220(3):623-36. PubMed ID: 7028271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term restricted insulin production in obese-hyperglycemic (genotype ob/ob) mice.
    Boozer CN; Mayer J
    Diabetologia; 1976 May; 12(2):181-7. PubMed ID: 131728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice.
    Bailey CJ; Flatt PR; Atkins TW
    Int J Obes; 1982; 6(1):11-21. PubMed ID: 7040265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine supplementation induces long-term beneficial effects on glucose homeostasis in ob/ob mice.
    Borck PC; Vettorazzi JF; Branco RCS; Batista TM; Santos-Silva JC; Nakanishi VY; Boschero AC; Ribeiro RA; Carneiro EM
    Amino Acids; 2018 Jun; 50(6):765-774. PubMed ID: 29556780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adrenalectomy on body weight and hyperglycemia in five months old Ob/Ob mice.
    Solomon J; Bradwin G; Cocchia MA; Coffey D; Condon T; Garrity W; Grieco W
    Horm Metab Res; 1977 Mar; 9(2):152-6. PubMed ID: 863380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse.
    Lavine RL; Voyles N; Perrino PV; Recant L
    Am J Physiol; 1977 Aug; 233(2):E86-90. PubMed ID: 329686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.